Summary by Moomoo AI
KOJI PHARMACEUTICAL HOLDINGS LIMITED (“KOJI PHARMACEUTICAL-B”) ANNOUNCED ON 26 MARCH 2024 THAT ITS BOARD OF DIRECTORS HAS PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION IN ORDER TO COMPLY WITH THE RULES ON THE LISTING OF SECURITIES OF THE HONG KONG STOCK EXCHANGE LIMITED, IN PARTICULAR REGARDING ISSUERS TO BE ISSUED ELECTRONICALLY TO SECURITIES HOLDERS FROM 31 DECEMBER 2023 New rules for corporate communications. In addition, the Board of Directors proposes the adoption of a revised and revised Articles of Association and Conditions, including all proposed amendments to the terms and conditions. These amendments and adoption will be subject to the approval of a special resolution by shareholders at the upcoming Annual General Meeting. The relevant Circulars and Notice of the Annual General Meeting will be published on the website of the Hong Kong Stock Exchange Limited and on the official website of Kozai Pharmaceuticals.